|
Drug | Delivery systems | Key observation | References |
|
Corticosteroids |
Prednisolone | Liposomes | Tissue targeting | [54] |
Microspheres | Prolonged release | [55] |
Nanoparticles | Improved efficacy | [56] |
|
DMARDS (Disease modifying antirheumatic drugs) |
Sod. aurothiomalate | Liposomes | Better safety profile and prolonged action | [11] |
Azathioprine | Sustain release tablets | Better patient safety | [57] |
Leflunomide | Microspheres | Rapid action | [58] |
Microcapsules | Sustained action | [59] |
Methotrexate | Multilamellar vesicles | Increased permeation | [60] |
Liposomes | Drug targeting, prolonged therapeutic effect | [61] |
Microspheres | Retention of drug in joints and less clearance into blood | [62] |
Encapsulated lipid based drug-delivery | Prolonged half-life, extended drug release | [63] |
Tacrolimus | Liposomes | Improved oral delivery | [64] |
|
NSAIDS (Nonsteroidal anti-inflammatory drugs) |
Diclofenac | Sustained release pellets | Less side effects | [65] |
Lipogelosomes | Less side effects, Improved efficacy | [66] |
Pharmacosomes | Improved solubility Lower gastrointestinal toxicity | [67] |
Microcapsules | Sustained release | [68] |
Microspheres | Long therapeutic effect | [69] |
Nanoparticles | Prolonged drug release | [47] |
Suppositories | Improved efficacy | [70] |
Ibuprofen | Microemulsions | Increased skin permeation, Increased oral bioavailability | [71, 72] |
Microspheres | Prolonged therapeutic effect | [73] |
Transfersome | Prolonged therapeutic effect and good stability | [74] |
Sustained release formulation | Prolonged therapeutic effect and improved patient compliance | [75] |
Indomethacin | Slow released formulations | Better safety and controlled release characteristics | [76, 77] |
Dendrimers | Targeted delivery | [78] |
Liposomes | More effective and minimum side effects | [79, 80] |
Microballoons | Good floating ability | [81] |
Microspheres | Improved targeting | [82] |
Nanoemulsions | Improved bioavailability through transdermal delivery | [83] |
Suppositories | Enhanced therapeutic efficacy | [84] |
Ketoprofen | Transdermal patch | Improved skin permeation | [85] |
Microspheres | Prolonged therapeutic effect | [86] |
Microcapsules | Optimum sustained release | [87] |
Nanoemulsions | Enhanced skin permeation | [88] |
|